SCHEMBL8306364

SCHEMBL8306364

Cc1ccc(N2CCNCC2=O)c(Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 5/20 0.46
SLC6A4 P31645 5/20 0.46
SLC6A3 Q01959 5/20 0.46
ALDH1A1 P00352 1/20 0.41
HTR1A P08908 3/20 0.40
HTR3A P46098 3/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
HTR2A P28223 3/20 0.39
HTR2C P28335 3/20 0.39
HTR2B P41595 3/20 0.39
HSD17B10 Q99714 1/20 0.38
METAP2 P50579 1/20 0.38
HSD11B1 P28845 1/20 0.37
P2RX7 Q99572 4/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8307179 0.85 HSD17B10 (0.44) SLC6A2SLC6A4SLC6A3ALDH1A1HTR1A
SCHEMBL3654179 0.84 P2RX7 (0.52) SLC6A2SLC6A4SLC6A3ALDH1A1HSD11B1
Hydrochloric Acid SCHEMBL2366300 0.84 HTR1A (0.45) SLC6A2SLC6A4SLC6A3ALDH1A1HTR1A
SCHEMBL8306413 0.82 HTR1A (0.39) SLC6A2SLC6A4SLC6A3ALDH1A1HTR1A
Hydrochloric Acid SCHEMBL1662951 0.81 HTR2A (0.41) SLC6A2SLC6A4SLC6A3ALDH1A1HTR1A
Hydrochloric Acid SCHEMBL1663244 0.81 HTR3A (0.46) SLC6A2SLC6A4SLC6A3HTR1AHTR3A
SCHEMBL8305437 0.80 MEN1 (0.41) ALDH1A1HTR1AHTR3ACYP1A2CYP3A4
SCHEMBL1814949 0.78 ADRB1 (0.56) SLC6A2SLC6A4SLC6A3HTR2AHTR2C
SCHEMBL10081863 0.78 ALDH1A1 (0.51) SLC6A2SLC6A4SLC6A3ALDH1A1HSD17B10
SCHEMBL8305501 0.77 HSD17B10 (0.50) ALDH1A1CYP3A4CYP2C9HSD17B10METAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004082687-A1 LACTAM-CONTAINING CYCLIC DIAMINES AND DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-09-30 WO disclosed